id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-348927-g69gt0oh	Li, Tong	Acute Respiratory Distress Syndrome Treated with Awake Extracorporeal Membrane Oxygenation in a Patient with COVID-19 Pneumonia	2020-11-10		.txt	text/plain	1558	106	50	title: Acute Respiratory Distress Syndrome Treated with Awake Extracorporeal Membrane Oxygenation in a Patient with COVID-19 Pneumonia Extensive use of mechanical respiratory support and extracorporeal membrane oxygenation (ECMO) has helped to reduce the case fatality rate of COVID-19 to less than 2% in some regions. Awake and fully mobile ECMO have proven to be beneficial in patients with ARDS induced by pneumocystis pneumonia, immunocompromised patients, and patients requiring extracorporeal life support. [5] [6] [7] However, the use of awake ECMO has not been reported in ARDS patients secondary to COVID-19 pneumonia. Profound hypoxemia and acute lung failure, the main causes of death, are the prominent features of ARDS resulting in a subset of critical COVID-19 pneumonia patients. 8 ECMO has become an alternative therapy for prolonging patient life and allowing time for lung recovery, especially in severe ARDS resulting from COVID-19. Better be awake"-a role for awake extracorporeal membrane oxygenation in acute respiratory distress syndrome due to Pneumocystis pneumonia	./cache/cord-348927-g69gt0oh.txt	./txt/cord-348927-g69gt0oh.txt